"There is no known local transmission of mpox clade I in New York City and the risk remains low for New Yorkers. The NYC Health Department recommends that New Yorkers who are at risk for mpox receive and complete the two-dose vaccine series that works to prevent mpox."
"Of the two types of mpox, clade I is known to cause more severe disease and death. It's the 12th clade I mpox diagnosis in the U.S. The city's Health Department said the person who tested positive recently traveled to Europe and is isolating until symptoms subside."
"Health officials say people who have sex with men and identify as male, trans, nonbinary or gender non-conforming, people who are planning to visit a country where mpox is spreading and anticipate sex with a new partner while there, and people who have been in close contact with someone they suspect has mpox should talk to their doctors about vaccination."
New York City health officials confirmed the first clade I mpox case in the city, marking the 12th diagnosis in the United States. The infected individual recently traveled to Europe and is isolating. Clade I mpox is more severe and potentially fatal compared to clade II. Health Commissioner Dr. Alister Martin emphasized that local transmission risk remains low and recommended vaccination for at-risk groups, including men who have sex with men, transgender and nonbinary individuals, travelers to affected regions, and those with close contact to suspected cases. Previously vaccinated individuals need not receive additional doses. New York City reported 398 clade II cases last year and 45 cases through March 10 this year.
Read at Cbsnews
Unable to calculate read time
Collection
[
|
...
]